We are live on ! Find out more
MURA icon

Mural Oncology

Delisted

MURA was delisted on the 4th of December, 2025.

77 hedge funds and large institutions have $30.2M invested in Mural Oncology in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 23 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

1% more funds holding

Funds holding: 76 → 77 (+1)

0.92% less ownership

Funds ownership: 55.88% → 54.96% (-0.92%)

2% less capital inflows, than outflows

Capital inflows: $6.13M | Capital outflows: $6.23M

26% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 23

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $111K

Holders
77
Holders Change
+1
Holders Change %
+1.32%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
17
Reduced
23
Closed
10
Calls
–
Puts
$111K
Net Calls
-$111K
Net Calls Change
-$124K

MURA Hedge Fund Activity: Q4 2024 in Review

77 of the 7,626 institutional investors tracked by Wall St. Rank reported a position in Mural Oncology (MURA) for Q4 2024, worth a combined $30.2M — up 1.3% from $29.8M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new MURA positions and 10 closed out — a net gain of 1 holder — while 17 added to existing stakes and 23 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $311K. The largest seller was Alta Fundamental Advisers, exiting entirely with an estimated $2.25M sold.

  • 77 institutional investors held Mural Oncology (MURA) as of Q4 2024, up from 76 in Q3 2024.
  • Funds reported $30.2M of Mural Oncology stock for Q4 2024, up 1.3% quarter-over-quarter.
  • 11 funds opened new Mural Oncology positions in Q4 2024 and 10 closed out, a net change of +1 holder.
  • The largest Mural Oncology buyer in Q4 2024 was Citadel Advisors, an estimated $311K added.
  • The largest Mural Oncology seller in Q4 2024 was Alta Fundamental Advisers, an estimated $2.25M sold.

Based on aggregated 13F filings for Q4 2024.